Wilson Sonsini Goodrich & Rosati (Boston) Wilson Sonsini Goodrich & Rosati (London)

Beau Buffier

Wilson Sonsini Goodrich & Rosati (Boston), Wilson Sonsini Goodrich & Rosati (London)
Partner

Beau Buffier is an antitrust and competition partner in the Boston and London offices of Wilson Sonsini Goodrich & Rosati, where his practice focuses on global mergers and agency investigations, complex litigation, and grand jury matters. He represents clients before the U.S. agencies as well as before the UK Competition Authority (CMA) and European Commission. Prior to joining the firm, Beau Buffier served as the Antitrust Bureau Chief at the New York Office of the Attorney General (NYOAG), where he led several groundbreaking antitrust enforcement initiatives and helped the NYOAG become the leading state antitrust enforcement unit in the country. Previously, Beau Buffier co-led the global antitrust practice at Shearman & Sterling, where he oversaw the expansion of its European competition law practice and helped raise the firm’s profile in Asia. He also led Shearman’s diversity and pro bono efforts, with a focus on matters assisting LGBT clients. Earlier in his career, he worked in the Sydney office of Mallesons Stephen Jacques (now King & Wood Mallesons).

Distinctions

Linked authors

Wilson Sonsini Goodrich & Rosati (New York)
Wilson Sonsini Goodrich & Rosati (Washington)
Wilson Sonsini Goodrich & Rosati (New York)
Wilson Sonsini Goodrich & Rosati (Brussels)
Wilson Sonsini Goodrich & Rosati

Articles

2914 Bulletin

Beau Buffier, Kelly Karapeytan The US DoJ fines a record $11 million an activist investor for violations of the HSR Act and agrees to injunctive relief to settle allegations (ValueAct)

328

On July 12, 2016, the US Department of Justice (“DOJ”) announced that activist investor ValueAct Capital agreed to pay a record $11 million fine and also agreed to injunctive relief to settle allegations that ValueAct violated the Hart-Scott-Rodino Antitrust Improvements Act of 1976, 15 U.S.C. § (...)

Beau Buffier, Heather Lamberg Kafele, Wayne Dale Collins The US Federal Trade Commission revises and raises the thresholds for the Hart-Scott-Rodino Antitrust Improvements Act of 1976

207

The US Federal Trade Commission (“FTC”) has revised and, once again, raised the thresholds for the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”). The HSR Act may require that parties to proposed stock or asset acquisitions exceeding certain thresholds file (...)

Beau Buffier, Heather Lamberg Kafele, Karina Lubell, Mark Lanpher, Steve L. Camahort The US FTC clears a merger between the two most-visited online home shopping sites in the US without conditions (Zillow / Trulia)

224

In a ruling on February 13, the FTC unconditionally approved the Zillow-Trulia merger after an intensive six-month antitrust review. Despite reported concerns “that the merger might concentrate too much power in one company,” the FTC ultimately decided to “bless” the Zillow-Trulia combination. (...)

Beau Buffier, Heather Lamberg Kafele, Stephen Mavroghenis The US Court of Appeals for the Seventh Circuit rules that cellphones manufacturer cannot recover overcharges to its non-U.S. subsidiaries that purchased price-fixed LCD panels abroad (Motorola / AU Optronics)

1451

This article has been nominated for the 2015 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. The Seventh Circuit Court of Appeals ruled that Motorola cannot recover overcharges to its non-U.S. subsidiaries that purchased price-fixed LCD panels abroad, (...)

Adam S. Hakki, Beau Buffier, Brian G. Burke, Heather Lamberg Kafele, Jerome S. Fortinsky, Richard F. Schwed, Stephen Fishbein, Stephen Mavroghenis The US District Court for the Eastern District of New York awards plaintiffs $162 million in first-ever civil price-fixing verdict against Chinese companies (In re Vitamin C Antitrust Litigation)

218

On March 14, 2013, a federal jury in Brooklyn, New York returned a verdict in In re Vitamin C Antitrust Litigation, No. 1:06-md-1738 (E.D.N.Y.), finding that two Chinese companies had unlawfully fixed prices and controlled the supply of vitamin C exports from China to the United States. (...)

Beau Buffier, Heather Lamberg Kafele, Jessica K. Delbaum, Kelly Karapeytan, Kenneth S. Prince, Lisl J. Dunlop, Wayne Dale Collins The US FTC fines company for failing to file a premerger notification and observe the statutory waiting period (Biglari)

171

This article has been nominated for the 2013 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. Passive Investors Beware: Recent FTC Fine Affirms Narrow Scope of HSR Exemption * In fining Biglari Holdings $850,000 for failing to file a premerger (...)

562 Review

Send a message